Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients (Q41663934)
Jump to navigation
Jump to search
scientific article published on 2 November 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients |
scientific article published on 2 November 2014 |
Statements
1 reference
Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients (English)
1 reference
Josep M Gatell
1 reference
Javier O Morales-Ramirez
1 reference
Debbie P Hagins
1 reference
Melanie Thompson
1 reference
Arasteh Keikawus
1 reference
Christian Hoffmann
1 reference
Sorin Rugina
1 reference
Olayemi Osiyemi
1 reference
Simona Escoriu
1 reference
Robin Dretler
1 reference
Charlotte Harvey
1 reference
Xia Xu
1 reference
Hedy Teppler
1 reference
1 reference
Identifiers
1 reference